Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Synthetic Anti-infective Drugs >  Antiviral drugs >  Baloxavir

Baloxavir

Basic information Uses Safety Supplier Related

Baloxavir Basic information

Product Name:
Baloxavir
Synonyms:
  • Baloxavir
  • CPD2051
  • Baloxavir Impurity 10
  • S-033447
  • New Baloxavir
  • 1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-, (12aR)-
  • Baloxavir USP/EP/BP
  • (R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2’4]triazine-6,8- dione
CAS:
1985605-59-1
MF:
C24H19F2N3O4S
MW:
483.49
EINECS:
200-001-8
Product Categories:
  • API
  • 1985605-59-1
Mol File:
1985605-59-1.mol
More
Less

Baloxavir Chemical Properties

Boiling point:
644.7±65.0 °C(Predicted)
Density 
1.63±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:41.67(Max Conc. mg/mL);86.19(Max Conc. mM)
form 
A solid
pka
4.50±1.00(Predicted)
color 
White to yellow
CAS DataBase Reference
1985605-59-1
More
Less

Baloxavir Usage And Synthesis

Uses

Baloxavir is a drug employed in the treatment of influenza virus infection.
Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents.

Uses

Baloxavir is a drug employed in the treatment of influenza virus infection.

Mechanism of action

Baloxavir marboxil is an influenza therapeutic agent, specifically, an enzyme inhibitor targeting the influenza virus' cap-dependent endonuclease activity, one of the activities of the virus polymerase complex. In particular, it inhibits a process known as cap snatching, by which the virus derives short, capped primers from host cell RNA transcripts, which it then uses for polymerase-catalyzed synthesis of its needed viral mRNAs. A polymerase subunit binds to the host pre-mRNAs at their 5' caps, then the polymerase's endonuclease activity catalyzes its cleavage "after 10–13 nucleotides". As such, its mechanism is distinct from neuraminidase inhibitors such as oseltamivir and zanamivir.

Side effects

Common side effects following the single dose administration of baloxavir marboxil include diarrhea, bronchitis, common cold, headache, and nausea. Adverse events were reported in 21% of people who received baloxavir, 25% of those receiving placebo, and 25% of oseltamivir.

BaloxavirSupplier

Yunfei Pharmaceutical(Shenzhen) Co., Ltd. Gold
Tel
0755-61160828 15994832653
Email
hulixiu@yunfeipharma.com
Jiangsu Vcare PharmaTech Co., Ltd. Gold
Tel
13327700685
Email
sales@vcarepharmatech.com
Hubei Kele Fine Chemical Co., Ltd Gold
Tel
027-59101668 19945030958
Email
2881924765@qq.com
Cangzhou Kangrui Medical Technology Co., LTD Gold
Tel
18632776803
Email
355803330@qq.com
BOYAN PHARMA Gold
Tel
18915538011
Email
liwei@boyanpharma.com